No Data
No Data
No Data
No Data
No Data
醫脈通:年報2023
Futu NewsApr 26 21:33 · Announcements
What logic? A-share fund managers bought Hong Kong stocks and only dared to take a heavy stock of pharmaceuticals...
Securities TimesApr 7 15:52
MEDLIVE To Go Ex-Dividend On May 28th, 2024 With 0.1375 HKD Dividend Per Share
March 26th - $MEDLIVE(02192.HK)$ is trading ex-dividend on May 28th, 2024. Shareholders of record on May 29th, 2024 will receive 0.1375 HKD dividend per share on June 24th, 2024. The ex-dividend d
Futu NewsMar 26 17:05
Selected announcements | CNPC's net profit last year exceeded 160 billion yuan; Pharmaceutical Federation's annual profit increased by more than 80% year-on-year
China Overseas Hongyang Group: Net profit of 2023 was 2.02 billion yuan, down 26.94% year on year; Zero Sports Auto: 2023 revenue of 16.747 billion yuan, up 35.22% year on year; Tencent Holdings: spent HK$1,001 billion to buy back 3.47 million shares on March 25.
cls.cnMar 26 08:10
Medical Pulse (02192) will pay a final dividend of $0.1248 per share on June 24
Medical Pulse (02192) announced that the company will distribute it on June 24, 2024 until 2024 until 2023...
Zhitong FinanceMar 25 18:58
Yimaitong (02192.HK)'s annual adjusted net profit of about 271 million yuan increased by about 86.8% year-on-year
Gelonghui (02192.HK) announced on March 25, that for the year ended December 31, 2023, the Group's revenue was approximately RMB 412.0 million, an increase of 31.2% over the same period last year. While expanding revenue, the Group continued to increase its profitability. The Group's net profit increased from RMB 126.4 million for the year ended December 31, 2022 to RMB 251.8 million for the year ended December 31, 2023, an increase of 99.1% over the previous year. Net profit margin increased by approximately 40.3% for the year ended December 31, 2022
Gelonghui FinanceMar 25 18:54
No Data
No Data